iRhythm Holdings, Inc. (IRTC)
117.00
-1.22
(-1.03%)
USD |
NASDAQ |
Apr 02, 12:48
iRhythm Holdings Research and Development Expense (TTM) : 84.61M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tandem Diabetes Care, Inc. | 192.28M |
| ICU Medical, Inc. | 87.50M |
| Merit Medical Systems, Inc. | 97.35M |
| Abbott Laboratories | 2.89B |
| Plus Therapeutics, Inc. | 8.379M |